Literature DB >> 8437650

[Monoamine oxidase inhibitors in the treatment of obsessive disorders. Two case reports and review of the literature].

A Erfurth1, M Schmauss.   

Abstract

Two patients who were admitted to hospital with severe obsessive compulsive disorders (OCD) improved dramatically after treatment with the MAO-Inhibitor tranylcypromine. The possibility of treating obsessive-compulsive disorders with MAO-Inhibitors and serotonergic drugs is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8437650

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  2 in total

1.  Obsessive Compulsive and Related Disorders: From the Biological Basis to a Rational Pharmacological Treatment.

Authors:  Gabriele Sachs; Andreas Erfurth
Journal:  Int J Neuropsychopharmacol       Date:  2018-01-01       Impact factor: 5.176

2.  Monoamine Oxidase A Hypomethylation in Obsessive-Compulsive Disorder: Reversibility By Successful Psychotherapy?

Authors:  Miriam A Schiele; Christiane Thiel; Jürgen Deckert; Michael Zaudig; Götz Berberich; Katharina Domschke
Journal:  Int J Neuropsychopharmacol       Date:  2020-05-27       Impact factor: 5.176

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.